Summary Judgment Denied In Depakote Birth Defect Case

(April 6, 2016, 7:48 AM EDT) -- ST. LOUIS — A Missouri federal judge on March 31 denied summary judgment in a Depakote birth defect trial, saying there is a question of whether the drug’s label should have had a better warning about the risk of spina bifida, that the drug should be avoided in women of childbearing age and that such women should use contraception (B.F., et al. v. Abbott Laboratories, Inc., et al., No. 12-1760, E.D. Mo., Eastern Div.; 2016 U.S. Dist. LEXIS 42935).

(Opinion available. Document #28-160407-033Z.)

In 1999, Beth...
To view the full article, register now.